Global Glycomics Glycobiology Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
24.43 Billion
USD
70.66 Billion
2024
2032
 Período de previsão |
2025 –2032 |
 Tamanho do mercado (ano base ) | USD 24.43 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 70.66 Billion |
 CAGR |
% |
| Principais participantes do mercado |
|
Global Glycomics/Glycobiology Market Segmentation, By Product (Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates), Application (Drug Discovery and Development, Disease Diagnostics, Other Application), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) – Industry Trends and Forecast to 2032.
Glycomics/Glycobiology Market Analysis
One of the most frequent alterations for cell survival is the attachment of glycans. Two types of glycosylation exist. One is N-linked glycosylation: Asparagine glycan attachment and other is O-linked glycosylation: when the glycan is connected to a serine or threonine. Glycomics is a rapidly developing scientific subject that focuses on explaining how glycans operate in biosystems.
Glycomics/Glycobiology Market Size
Global glycomics/glycobiology market size was valued at USD 24.43 billion in 2024 and is projected to reach USD 70.66 billion by 2032, with a CAGR of 14.2% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Glycomics/Glycobiology Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Merck KGaA (Germany), Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Shimadzu Corporation (Japan), Takara Bio Inc. (Japan), Waters Corporation (U.S.), Asparia Glycomics S.L. (Spain), Bio-Techne (U.S.), Bruker (U.S.), Danaher (U.S.), RayBiotech, Life Inc. (U.S.), Z Biotech LLC (U.S.), Chemily Glycoscience (U.S.), Dextra Laboratories Ltd. (U.K.), Lectenz Bio (U.S.), and Ludger Ltd. (U.K.) |
|
Market Opportunities |
|
Glycomics/Glycobiology Market Definition
The study of saccharides, which are extensively distributed in nature and are also thought as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Each and every living thing contains glycans. Biotechnology, biomedicine, and basic research are all interested in glycobiology's rapidly developing biological topic.
Glycomics/Glycobiology Market Dynamics
Drivers
- Technological advancements
Technological advancements are thought to promote corporate expansion. Other important aspects that operate as determinants include rising analysis spending by various administration groups and the development of novel drugs by biotechnology and pharmaceutical firms. Additionally, throughout the 2025–2032 forecast period, increasing interest in proteomics examination learnings is anticipated to fuel market growth.
- Rising R&D expenditures
The market is expanding primarily due to rising glycomics research efforts, rising R&D expenditures by pharmaceutical and biotechnology firms, and expanding proteomics sales. On the other hand, developing nations like China and India provide profitable chances for business in this sector.
- Rise in the geriatric population
The rising prevalence of disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the global glycomics/glycobiology market.
Opportunities
The market for glycomics and glycobiology is being driven primarily by rising investments in research and development by pharmaceutical and biotechnology businesses and expansion in the proteomics sector. For other businesses in this industry, developing nations provide lucrative opportunities.
Restraints/Challenges
On the other hand, the huge expense of devices will obstruct the market's growth rate.
This glycomics/glycobiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycomics/glycobiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Glycomics/Glycobiology Market Scope
The glycomics/glycobiology market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Enzymes
- Glycosidases and Neuramidases
- Glycosyltransferases and Sialytransferases
- Other Enzymes
- Carbohydrate kinases
- Carbohydrate sulfotransferases
- Protein sulfotransferases
- Sulfatases
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments
- electrophoresis instruments
- NMR instruments
- HPLC columns
- Kits
- Glycan Releasing Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Other Kits
- Glycan detection kits
- Glycan enrichment kits
- Glycan sample preparation kits
- Carbohydrates
- Oligosaccharides
- Monosaccharides
- Other Carbohydrates
- Rare sugars
- Glycoproteins
- Glycolipids
- Glycol peptides
- Reagents and Chemicals
Application
- Drug Discovery and Development
- Disease Diagnostics
- Other Applications
- Virology
- Cell biology
- Microbiology
End-user
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
Glycomics/Glycobiology Market Regional Analysis
The glycomics/glycobiology market is analyzed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the glycomics/glycobiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glycomics/glycobiology market due to increased funding for glycomics research, rising R&D spending in pharmaceutical companies for the creation of new medicines, and the close proximity of the necessary personnel.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2025 to 2032 owing to the rising health awareness among the people and rising demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Glycomics/Glycobiology Market Share
The glycomics/glycobiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycomics/glycobiology market.
Glycomics/Glycobiology Market Leaders Operating in the Market Are:
- Merck KGaA (Germany)
- Agilent Technologies Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Takara Bio Inc. (Japan)
- Waters Corporation (U.S.)
- Asparia Glycomics S.L. (Spain)
- Bio-Techne (U.S.)
- Bruker (U.S.)
- Danaher (U.S.)
- RayBiotech, Life Inc. (U.S.)
- Z Biotech LLC (U.S.)
- Chemily Glycoscience (U.S.)
- Dextra Laboratories Ltd. (U.K.)
- Lectenz Bio (U.S.)
- Ludger Ltd. (U.K.)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
